Manufactured by: Theratechnologies Inc., 2015 Peel Street, Suite 1100, Montral, Qubec, Canada H3A 1T8 Revised: March 2025 EGRIFTA WR is a trademark of Theratechnologies Inc
Commercially available 1-stearoyl-2-15(S)-HpETE-sn-glycero-3-phosphoethanolamine, 1-stearoyl-2-15(S)-HETE-sn-glycero-3-phospho-ethanolamine (Cayman Chemicals), 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethano-lamine, 1,2-dioleoyl-sn-glycero-3-phospho-ethanolamine, 1-palmitoyl-2-(5-oxo-valeroyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phosphocholine (Avanti Polar Lipids) were used as reference standards
Role of other factors on TRP channels and pain In addition to the oxidative stress, several other factors play a role in the induction of CIPN with/without TRP channel activation, including glutamate receptors, neuropeptides, PKC and inflammation
Budget constraints may favor minoxidil for those seeking the most affordable ongoing treatment
doi:10.1038/clpt.2010.67
Verify current terms by viewing the current ProHealth BPC-157 offer (official ProHealth page)